The third iteration of the mhGAP guideline has been released to provide non-specialist health workers in low and middle-income countries with high-quality, timely, transparent, and evidence-based guidance for treating and caring for individuals with mental, neurological, and substance use (MNS) conditions. With 30 updated recommendations and 18 new ones added to the previous 90 recommendations, this latest edition aims to address the growing need for improved capacity to tackle MNS challenges.
The mhGAP programme has received significant investment over the past 15 years, resulting in a comprehensive guide that is widely recognized as a valuable resource for healthcare professionals. The revised recommendations are designed to ensure that mhGAP remains relevant and effective in supporting non-specialist health workers in delivering quality care to individuals with MNS conditions.
In order to narrow the treatment gap, the latest edition of the guideline includes recommendations on improving access to mental health services, enhancing early detection and diagnosis of MNS conditions, and increasing awareness about stigma associated with these conditions. Additionally, the guidelines offer practical advice on how to assess patients’ needs, develop treatment plans, and monitor their progress.
Overall, the mhGAP guideline is an essential tool for healthcare professionals working in low and middle-income countries who are committed to providing high-quality care for individuals with MNS conditions. By following these evidence-based recommendations, they can improve patient outcomes and reduce the treatment gap faced by millions of people worldwide.